PERIPHERAL BLOOD EOSINOPHILIA PREDICTS EARLIER ANTI-TNF CESSATION AND BIOLOGIC SWITCH IN ULCERATIVE COLITIS PATIENTS: A COHORT ANALYSIS

被引:0
|
作者
Nguyen, Thien-Bao P.
Wang, Xianling
Rivers, Claudia Ramos
Park, Yongseok
Koutroubakis, Ioannis E.
Hashash, Jana G.
Dunn, Michael A.
Barrie, Arthur
Schwartz, Marc
Babichenko, Dmitriy
Tang, Gong
Proksell, Siobhan
Johnston, Elyse
Dueker, Jeffrey
Binion, David G.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1885
引用
收藏
页码:S465 / S465
页数:1
相关论文
共 50 条
  • [1] BASELINE PERIPHERAL BLOOD EOSINOPHILIA PREDICTS DECREASED RESPONSE TO INITIAL ANTI-TNF BIOLOGIC THERAPY IN IBD
    Koutroumpakis, Filippos
    Rivers, Claudia Ramos
    Ghaffari, Amir A.
    Gkiaouraki, Eugenia
    Johnston, Elyse
    Dueker, Jeffrey
    Schwartz, Marc
    Barrie, Arthur
    Dunn, Michael A.
    Babichenko, Dmitriy
    Tang, Gong
    Koutroubakis, Ioannis E.
    Binion, David G.
    GASTROENTEROLOGY, 2022, 162 (07) : S808 - S809
  • [2] Outcome in ulcerative colitis after switch from subcutaneous anti-TNF to intravenous anti-TNF: A multicentre study
    Viola, A.
    Pugliese, D.
    Renna, S.
    Furfaro, F.
    Caprioli, F.
    D'Inca', R.
    Bossa, F.
    Costantino, G.
    Fantini, M.
    Fiorino, G.
    Armuzzi, A.
    Orlando, A.
    Fries, W.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S418 - S418
  • [3] OUTCOME IN ULCERATIVE COLITIS AFTER SWITCH FROM SUBCUTANEOUS ANTI-TNF TO INTRAVENOUS ANTI-TNF: A MULTICENTRE STUDY
    Viola, A.
    Pugliese, D.
    Renna, S.
    Furfaro, F.
    Caprioli, F.
    D'Inca, R.
    Bossa, F.
    Costantino, G.
    Fantini, M. C.
    Fiorino, G.
    Armuzzi, A.
    Orlando, A.
    Fries, W.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E193 - E193
  • [4] Editorial: which biologic is next for ulcerative colitis patients who fail a subcutaneous anti-TNF?
    Albshesh, Ahmad
    Ben-Horin, Shomron
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (11) : 1198 - 1199
  • [5] Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumab
    Miller, Charles
    Kwok, Hanson
    Harrow, Paul
    Vega, Roser
    Seward, Edward
    Mehta, Shameer
    Rahman, Farooq
    McCartney, Sara
    Parisi, Ioanna
    Lim, Samuel Hsiang
    Sharma, Esha
    Samaan, Mark A.
    Bancil, Aaron
    Kok, Klaartje Bel
    Shalabi, Ahmed
    Johnston, Emma L.
    Katarey, Dev
    Taherzadeh, Nina
    Murray, Charles
    Sharip, Mohammed Tauseef
    Carter, Martyn J.
    Radhakrishnan, Shiva T.
    Peake, Simon
    Khakoo, Imran
    Wahed, Mahmood
    Povlsen, Sebastian
    Patel, Mehul
    DuBois, Patrick
    Finkel, Jemima
    Onnie, Clive
    Bloom, Stuart
    FRONTLINE GASTROENTEROLOGY, 2022, 13 (05) : 392 - 401
  • [6] REAL LIFE COMPARISON OF DIFFERENT ANTI-TNF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS TREATMENT: A RETROSPECTIVE COHORT STUDY
    Barberio, B.
    Zingone, F.
    Marinelli, C.
    Maccarone, M. C.
    Ghisa, M.
    Massimi, D.
    Gubbiotti, A.
    D'Inca, R.
    Savarino, E. V.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S118 - S118
  • [7] Patients with ulcerative colitis show increased Treg number in peripheral blood after 1 year of anti-TNF therapy
    Kyurkchiev, D.
    Ivanova-Todorova, E.
    Spasova, Z.
    Velikova, T.
    Petkova, M.
    Krasimirova, E.
    Tumangelova-Yuzeir, K.
    Mateva-Vladimirova, L.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S137 - S137
  • [8] Real-Life Comparison of Different Anti-TNF Biologic Therapies for Ulcerative Colitis Treatment: A Retrospective Cohort Study
    Barberio, Brigida
    Zingone, Fabiana
    Frazzoni, Leonardo
    D'Inca, Renata
    Maccarone, Maria Chiara
    Ghisa, Matteo
    Massimi, Davide
    Lorenzon, Greta
    Savarino, Edoardo Vincenzo
    DIGESTIVE DISEASES, 2021, 39 (01) : 16 - 24
  • [9] Real-life comparison of different anti-TNF biologic therapies for ulcerative colitis treatment: A retrospective cohort study
    Barberio, B.
    Zingone, F.
    D'Inca, R.
    Marinelli, C.
    Maccarone, M. C.
    Gubbiotti, A.
    Cingolani, L.
    Lorenzon, G.
    Ghisa, M.
    Savarino, E. V.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S548 - S549
  • [10] Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naive patients with ulcerative colitis
    De Vos, M.
    Dewit, O.
    D'Haens, G.
    Baert, F.
    Fontaine, F.
    Vermeire, S.
    Franchimont, D.
    Moreels, T.
    Staessen, D.
    Terriere, L.
    Vander Cruyssen, B.
    Louis, E.
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (05): : 557 - 562